ELI LILLY & Co — Director's Dealing 2018

Dec 4, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2018-12-02

Reporting Person: White Anne E. (SVP & Pres-Lilly Oncology)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-12-02	Common Stock	M	7500	—	Acquired	17103	Direct
2018-12-02	Common Stock	F	3306	$118.64	Disposed	13797	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-12-02	Restricted Stock Unit	$	M	7500	Disposed	2018-12-02	Common Stock (7500.0)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.